Trademark Overview
On Tuesday, February 13, 2024, a trademark application was filed for NXERA with the United States Patent and Trademark Office. The USPTO has given the NXERA trademark a serial number of 98403442. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, July 16, 2024. This trademark is owned by Sosei Group Corporation. The NXERA trademark is filed in the Advertising, Business and Retail Services, Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations; medicines; biological products for medical purposes, namely, G-protein coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; biological products for use in chemical and biological drug discovery, lead identification and diagnostics; biological products for therapeutic purposes; biological formulation for developing chemical and biological pharmaceutical products; biological formulation for identifying lead chemical and biological products; biological formulation for diagnostic use; biological formulation for therapeutic use; proteins ...
Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery; business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations.
Chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses; proteins and Gprotein- coupled receptors for manufacturing pharmaceutical products; proteins and G-protein-coupled receptors for the research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics; proteins and G-protein-coupled receptors for drug discovery purposes; chemicals and biologicals, including proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequen...
Pharmaceutical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes; all of the aforesaid relating to drug discovery and use of Gprotein- coupled receptors in the design and development of pharmaceutical products.
Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; ...
